The two recurrent fusions (ADAP1‐NOC4L and RNF43‐SUPTH1) out of five chimeras were validated in SW48 and HT29 colon cancer cell lines as well as patient tissue samples (Figures 3, 4). Here, ADAP1 is linked to malignant colon neoplasm.